Partnership Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
MSV
VWM
SIS
QPBE
FFA
RT
WF
AAA
ACM
Partnership Wealth Management's PFE Position: Q3 2026 in Review
Partnership Wealth Management reduced its Pfizer (PFE) stake by 0.55% in Q3 2026, selling an estimated $4.31K and leaving 29,452 shares worth $840K. The position accounts for 0.6% of the portfolio, ranked #33.
Partnership Wealth Management first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. The position peaked at $852K in Q3 2024. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Partnership Wealth Management held 29,452 shares of Pfizer worth $840K as of Q3 2026.
- Partnership Wealth Management sold 162 Pfizer shares in Q3 2026, an estimated $4.31K.
- Pfizer made up 0.6% of Partnership Wealth Management's portfolio in Q3 2026, its #33 holding.
- Partnership Wealth Management first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
- Partnership Wealth Management's Pfizer position peaked at $852K in Q3 2024.
- 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Partnership Wealth Management's 13F filing for Q3 2026, filed 5 Oct 2026.